Showing results (41-50 of 160) with videos related to

Sort By:
Pageof 16
Pharmacogenetics and Genomics|May 4, 2016
Vitamin D pathway gene polymorphisms as predictors of hepatitis C virus-related mixed cryoglobulinemiaJessica Cusato, Lucio Boglione, Amedeo De Nicolò, et al.
Cancer Chemotherapy and Pharmacology|May 20, 2026
Failure of a LHRH agonist in metastatic prostate cancer: a case report and review of literatureEleonora Paganoni, Paola Sabbadini, Antonio D'Avolio, et al.
Pharmacogenomics|April 29, 2017
Pharmacogenetic analysis of hepatitis C virus related mixed cryoglobulinemiaJessica Cusato, Lucio Boglione, Amedeo De Nicolò, et al.
Clinical and Experimental Pharmacology & Physiology|December 6, 2017
Clinical relevance of deferasirox trough levels in β-thalassemia patientsSarah Allegra, Davide Massano, Silvia De Francia, et al.
The Journal of Antimicrobial Chemotherapy|August 27, 2013
High interpatient variability of raltegravir CSF concentrations in HIV-positive patients: a pharmacogenetic analysisAndrea Calcagno, Jessica Cusato, Marco Simiele, et al.
Therapeutic Drug Monitoring|September 27, 2013
Ultra performance liquid chromatography PDA method for determination of tigecycline in human plasmaAntonio D'Avolio, Emanuela Peila, Marco Simiele, et al.
The Journal of Pharmacy and Pharmacology|October 24, 2017
Cannabinoids concentration variability in cannabis olive oil galenic preparationsChiara Carcieri, Cristina Tomasello, Marco Simiele, et al.
Methods (San Diego, Calif.)|March 2, 2026
Clinical assessment of the diagnostic performance of the LIAISON® Legionella urinary antigen assayJessica Cusato, Giorgia Menegatti, Monica Ravotto, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|July 10, 2015
Intracellular and Plasma Trough Concentration and Pharmacogenetics of TelaprevirJessica Cusato, Sarah Allegra, Amedeo De Nicolò, et al.
Pageof 16